Watermark Asset Management’s AbbVie ABBV Stock Holding History

Watermark Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$15K	Buy	164 +2	+1%	+$176	0.01%	149
2018 Q3	$15K	Buy	162 +1	+0.6%	+$95	0.01%	142
2018 Q2	$15K	Buy	161 +1	+0.6%	+$98	0.01%	141
2018 Q1	$15K	Buy	160 +1	+0.6%	+$110	0.01%	151
2017 Q4	$15K	Buy	159 +1	+0.6%	+$94	0.01%	155
2017 Q3	$14K	Buy	158 +1	+0.6%	+$76	0.01%	156
2017 Q2	$11K	Buy	157 +1	+0.6%	+$67	0.01%	165
2017 Q1	$10K	Buy	+156	New	+$9.81K	﹤0.01%	167

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Watermark Asset Management's ABBV Position: Q4 2018 in Review

Watermark Asset Management increased its AbbVie (ABBV) stake by 1.2% in Q4 2018, buying an estimated $176 and bringing the position to 164 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #149.

Watermark Asset Management first reported a position in ABBV in Q1 2017 and has held it in 8 quarters since. 2,062 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

Watermark Asset Management held 164 shares of AbbVie worth $15K as of Q4 2018.
Watermark Asset Management bought 2 AbbVie shares in Q4 2018, an estimated $176.
AbbVie made up 0.01% of Watermark Asset Management's portfolio in Q4 2018, its #149 holding.
Watermark Asset Management first reported a position in AbbVie in Q1 2017 and has held it in 8 quarters since.
2,062 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Watermark Asset Management's 13F filing for Q4 2018, filed 14 Jan 2019.